Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ArthroCare Corporation Fourth Quarter 2002 Earnings Conference Call.


Business Editors

SUNNYVALE, Calif.--(BUSINESS WIRE)--Feb. 3, 2003

ArthroCare Corporation (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ARTC ARTC Arthrocare Corp (stock symbol)
ARTC Australian Rail Track Corporation
ARTC Air Route Traffic Control
ARTC Association de la Recherche Theatrale au Canada
ARTC Andean Root and Tuber Crops
), a multi-business medical device company that develops, manufactures and markets minimally invasive soft tissue surgical products based on its patented Coblation technology, will hold its quarterly conference call to discuss financial results for the fourth quarter and fiscal 2002 on Wednesday, February 5, 2003, at 8:00 a.m. Eastern Time (7 a.m. Central Time).

This call is being webcast by CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 and can be accessed at ArthroCare's web site at www.arthrocare.com.

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

About ArthroCare Corporation

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, CA, is a multi-business medical device company that develops, manufactures and markets minimally invasive soft tissue surgical products based on its patented Coblation technology. Coblation uses low-temperature radio-frequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties Medical Specialties
See also anatomy; disease and illness; drugs; health; remedies; surgery.

adenography

the science of the description of glands. — adenographic, adj.
, significantly improving surgical procedures Surgical procedures have long and possibly daunting names. The meaning of many surgical procedure names can often be understood if the name is broken into parts. For example in splenectomy, "ectomy" is a suffix meaning the removal of a part of the body. "Splene-" means spleen.  and enabling new, minimally invasive procedures Minimally invasive surgical procedures avoid open invasive surgery in favor of closed or local surgery with less trauma. These procedures involve use of laparoscopic devices and remote-control manipulation of instruments with indirect observation of the surgical field through an . ArthroCare's Coblation-based devices have been used in more than 1.75 million surgical procedures worldwide. The company has developed and marketed Coblation-based products for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology.  and laparoscopic/general surgical procedures, and continues research in other areas
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 3, 2003
Words:271
Previous Article:Crosswave Expands Access Line Availability for "Wide-Area Ethernet Platform Service".
Next Article:Cobalt Corporation and Wisconsin United for Health Foundation Announce Pricing of Secondary Offering.
Topics:



Related Articles
ArthroCare Reports Third Quarter Results; Results Include Provisions For Strategic Initiatives.
Arthrocare Net Income Up 186 Percent in Fiscal 2000; Product Sales Driven By Strong Growth In Arthroscopy.
ArthroCare Provides Business Outlook for Fiscal 2002; Company Plans To Double Operating Income, Profits To Increase By More Than 30 Percent.
ArthroCare Reports 23 Percent Revenue Growth in Fiscal 2001; Reports EPS of $0.43 for the Year, $0.10 for the Fourth Quarter.
ArthroCare Reports 18 Percent Product Sales Growth in Third Quarter; Net Income Impacted by Manufacturing and Sales Investments.
ArthroCare Reports Product Sales Growth of 21 Percent in Fiscal 2002.
ArthroCare Reports Revenues of $27.2 Million in the First Quarter of Fiscal 2003.
ArthroCare Announces Results of Annual Meeting of Stockholders; Company Reiterates Financial Guidance for Fiscal 2003.
ArthroCare to Hold Fourth Quarter 2003 Conference Call and Present at Piper Jaffray Health Care Conference.
ArthroCare Reports Record Revenues of $32.5 Million for the Fourth Quarter; Fiscal 2003 Revenues Grow 34 Percent to $118.9 Million with EPS Of $0.34.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles